MIRA INFORM REPORT
|
Report Date : |
03.10.2011 |
IDENTIFICATION DETAILS
|
Name : |
PHARMA COSTECH CO., LTD. |
|
|
|
|
Registered Office : |
91-20, Yongseong-ri, Samseong-myeon, Eumseong-gun, Chungcheongbuk-do,
Korea, Zip Code 369-834 |
|
|
|
|
Country : |
South Korea |
|
|
|
|
Financials (as on) : |
31.12.2009 |
|
|
|
|
Date of Incorporation : |
04.102000 |
|
|
|
|
Com. Reg. No.: |
303-81-27585 |
|
|
|
|
Legal Form : |
Co., Ltd by Shares |
|
|
|
|
Line of Business : |
Manufacture of all other Chemical Products |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment
Behaviour : |
Usually Correct |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2011
|
Country Name |
Previous Rating (31.12.2010) |
Current Rating (31.03.2011) |
|
South Korea |
a1 |
a1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Basic
|
Company
Name |
PHARMA COSTECH CO., LTD. (Korean Company Name : “(주)파마코스텍’) |
|
Registered Address |
91-20, Yongseong-ri, Samseong-myeon,
Eumseong-gun, Chungcheongbuk-do, Korea |
|
Zip Code |
369-834 |
|
Tel |
+82-43-882-5968~9 |
|
Fax |
+82-43-882-5967 |
|
E-mail |
|
|
Website |
|
|
Trading Address |
91-20,
Yongseong-ri, Samseong-myeon, Eumseong-gun, Chungcheongbuk-do, Korea |
|
Tel |
+82-43-882-5968~9 |
|
Fax |
+82-43-882-5967 |
|
Other Address-Hwaseong Factory |
D35-2B, Baran Industrial Complex,
Sangsin-ri, Hyangnam-eup, Hwaseong-si, Gyeonggi-do, Korea |
|
Tel |
+82-31-359-9967~9 |
|
Fax |
+82-31-359-9965 |
|
Type |
Export/Import |
|
Industry |
Manufacture of All Other Chemical Products n.e.c. |
|
Main Business |
Active Pharmaceutical Ingredient, Benzoic Acid |
|
Established (mm/dd/yyyy) |
10/04/2000 |
Detailed Products
|
Activity |
Detailed Products (UNSPSC) |
|
Sell |
Food or drug additives(12164500) |
|
Sell |
Cosmetics(53131619) |
|
Sell |
Drugs and Pharmaceutical Products(51000000) |
CEO’s
|
Name |
Kim Jae-Won |
|
Address |
Suite 107-2501, 888, Daechi-dong,
Gangnam-gu, Seoul, Korea |
|
Date of Birth |
10/23/1961 |
|
Title |
President & CEO |
|
Sex |
Male |
|
Nationality |
Korean |
Profiles
|
Capital (KRW) |
700,000,000 |
||||||||||||
|
Employees |
42 |
||||||||||||
|
Formation |
Co., Ltd by Shares |
||||||||||||
|
Bank Details |
Industrial Bank of Korea Hana Bank |
||||||||||||
|
Corporate Registered No. |
154511-0018683 |
||||||||||||
|
Business Registered No. |
303-81-27585 |
||||||||||||
|
Permit & Licenses |
03/2004 ISO9001 |
||||||||||||
|
Shareholder Position |
|
||||||||||||
|
Company History |
10/04/2000 Incorporated as the present name 03/26/2004 Increased the authorized shares
to 500,000 shares from 20,000 shares 05/11/2005 Increased capital to 700,000,000
KRW from 400,000,000 KRW |
||||||||||||
|
|
|
Management
|
Job Description |
Title |
Name |
Sex |
Nationality |
Inauguration Date |
|
President & CEO |
Mr. |
Kim Jae-Won |
Male |
Korean |
03/26/2004 |
|
Director |
Mr. |
Cha Young-Kwon |
Male |
Korean |
03/26/2010 |
|
Director |
Mr. |
Park Yong-Cheol |
Male |
Korean |
03/26/2010 |
|
Auditor |
M/S. |
Kang Yong-Sun |
Female |
Korean |
03/26/2010 |
Financials
|
Year / Unit : KRW |
Sales |
Assets |
Net Income |
|
|
|
|
|
|
2009 |
10,080,140,089 |
9,762,794,987 |
1,128,357,343 |
|
2008 |
11,038,462,282 |
10,322,535,792 |
893,162,268 |
|
2007 |
6,807,989,026 |
9,464,130,901 |
691,908,508 |
|
2006 |
6,856,656,970 |
9,778,659,259 |
836,079,901 |
The latest
financials are not available, and the Subject Company does not have any obligations
to release its financials to the public.
Financial Description
|
Authorized Capital(KRW) |
5,000,000,000 |
|
Paid-Up Capital(KRW) |
700,000,000 |
|
Total Issues Shares |
70,000 |
Balance
Sheet
|
|||
|
Unit : Korean Won |
As of 12/31/2009 |
As of 12/31/2008 |
As of 12/31/2007 |
|
Total Assets |
9,762,794,987 |
10,322,535,792 |
9,464,130,901 |
|
Current Assets |
3,827,572,663 |
4,460,059,038 |
3,385,291,748 |
|
-Quick Assets |
3,528,551,066 |
4,133,446,674 |
3,004,853,344 |
|
-Inventories |
299,021,597 |
326,612,364 |
380,438,404 |
|
Fixed Assets |
5,935,222,324 |
5,862,476,754 |
6,078,839,153 |
|
-Investment |
40,000,000 |
155,000,000 |
85,000,000 |
|
-Tangibles |
5,581,734,324 |
5,505,926,754 |
5,820,541,153 |
|
-Intangibles |
313,488,000 |
201,550,000 |
173,298,000 |
|
Total Liabilities |
3,427,038,474 |
5,115,136,622 |
5,236,706,332 |
|
Current Liabilities |
1,150,816,043 |
2,752,520,793 |
2,294,781,742 |
|
Fixed Liabilities |
2,276,222,431 |
2,362,615,829 |
2,941,924,590 |
|
Capital Stock |
700,000,000 |
700,000,000 |
700,000,000 |
|
Capital Surplus |
- |
- |
- |
|
Profit Surplus |
5,635,756,513 |
4,507,399,170 |
3,614,236,902 |
|
Capital Adjustment |
- |
- |
-86,812,333 |
|
Total Equity |
6,335,756,513 |
5,207,399,170 |
4,227,424,569 |
|
Liab. & Shareholder’s Equity |
9,762,794,987 |
10,322,535,792 |
9,464,130,901 |
|
Current Liabilities |
1,150,816,043 |
2,752,520,793 |
2,294,781,742 |
|
Trade Payables |
315,304,107 |
672,711,857 |
493,185,427 |
|
Short-Term Borrowings |
- |
1,000,000,000 |
1,000,000,000 |
|
Current Portion of Long-Term Debts |
600,000,000 |
800,000,000 |
351,800,000 |
|
Account Payables |
21,783,227 |
17,368,600 |
321,080,000 |
|
Withholdings |
18,228,010 |
14,622,580 |
12,319,920 |
|
VAT Withhold |
- |
8,837,320 |
- |
|
Accrued Income Tax |
- |
- |
- |
|
Accrued Expenses |
159,304,194 |
238,980,436 |
116,396,395 |
|
Advance Receipts |
36,196,505 |
- |
- |
|
Fixed Liabilities |
2,276,222,431 |
2,362,615,829 |
2,941,924,590 |
|
Long-Term Borrowings |
2,138,600,000 |
2,244,600,000 |
2,844,600,000 |
|
Provision for Severance & Retirement |
334,244,730 |
227,110,020 |
185,885,766 |
Income
Statement
|
|||
|
Unit : Korean Won |
As of 12/31/2009 |
As of 12/31/2008 |
As of 12/31/2007 |
|
Sales |
10,080,140,089 |
11,038,462,282 |
6,807,989,026 |
|
Cost of Sold Goods |
7,821,396,122 |
8,859,075,513 |
5,378,800,028 |
|
Gross Profit |
2,258,743,967 |
2,179,386,769 |
1,429,188,998 |
|
Selling & Admin. Expenses |
929,882,747 |
661,928,111 |
680,683,324 |
|
Operating Income |
1,328,861,220 |
1,517,458,658 |
748,505,674 |
|
Non-Operating Income |
312,183,640 |
200,144,208 |
259,273,304 |
|
Non-Operating Expenses |
507,480,323 |
707,904,548 |
281,156,875 |
|
Income Before Taxes |
1,133,564,537 |
1,009,698,318 |
726,622,103 |
|
Income Taxes Expenses |
5,207,194 |
116,536,050 |
34,713,595 |
|
Net Income |
1,128,357,343 |
893,162,268 |
691,908,508 |
Cash
Flows
|
|||
|
Unit : Korean Won |
As of 12/31/2009 |
As of 12/31/2008 |
As of 12/31/2007 |
|
Cash Flows from Operating |
1,999,460,363 |
1,371,568,128 |
1,143,455,870 |
|
-Net Income |
1,128,357,343 |
893,162,268 |
691,908,508 |
|
-Exp.
without Cash Outflow |
796,535,617 |
1,083,804,310 |
825,156,871 |
|
-Sale
without Cash Inflows |
-37,562,574 |
-996,234 |
-79,557,852 |
|
-Changes in
Asset/ & Liability |
112,129,977 |
-604,402,216 |
-294,051,657 |
|
Cash Flows
from Investing |
409,985,101 |
-810,640,787 |
-438,593,727 |
|
-Cash Inflow
from Investing |
3,125,607,295 |
1,494,178,757 |
1,071,621,753 |
|
-Cash
Outflows for Investing |
-2,715,622,194 |
-2,304,819,544 |
-1,510,215,480 |
|
Cash Flows
from Financing |
-1,306,000,000 |
-151,800,000 |
-785,902,156 |
|
-Cash
Inflows from Financing |
494,000,000 |
200,000,000 |
250,000,000 |
|
-Cash
Outflows from Financing |
-1,800,000,000 |
-351,800,000 |
-1,035,902,156 |
|
Increase/Decrease
in Cash |
1,103,445,464 |
409,127,341 |
-81,040,013 |
|
Cash at the
Beginning of Year |
620,389,843 |
211,262,502 |
292,302,515 |
|
Cash at the
End of Year |
1,723,835,307 |
620,389,843 |
211,262,502 |
Products, Technologies, Services Description
|
Main Products & Services |
Active Pharmaceutical Ingredient, Benzoic Acid |
Trade Partners & Competitors
|
Competitors |
CSF CORPORATION 167-12, ALLAK 2-DONG, DONGNAE-GU, BUSAN,
KOREA TEL:+82-51-531-8181 FAX:+82-51-531-8286 ILSHIN CHEMICAL CO., LTD. 287-2, BUKJEONG-DONG, YANGSAN-SI,
GYEONGSANGNAM-DO, KOREA TEL:+82-55-385-5826~7 FAX:+82-55-383-4808 ORAE FOOD CO., LTD. 103, GONJIAM-RI, SILCHON-EUP, GWANGJU-SI,
GYEONGGI-DO, KOREA TEL:+82-31-761-2733 FAX:+82-31-761-2735 |
Related Parties
(Subsidiaries, Joint-Venture & Affiliates)
|
Cooperative Enterprise |
-Insured Company DONGBU INSURANCE CO., LTD.(110111-0095285) |
Sales by Region
(Activity & Markets)
Not Available.
Court Action
Not Available.
News Clipping
---
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.48.93 |
|
UK Pound |
1 |
Rs.76.52 |
|
Euro |
1 |
Rs.66.65 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.